Clinical trial
Trial of High-dose Urso in Primary Sclerosing Cholangitis
NCT00059202 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00059202 |
|---|---|
| Title | Trial of High-dose Urso in Primary Sclerosing Cholangitis |
| Official title | Multicentered Randomized Trial of High-dose Urso in Primary Sclerosing Cholangitis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Primary Sclerosing Cholangitis |
| Intervention type | Drug |
| Interventions | Ursodeoxycholic Acid, Placebo |
| Enrollment | 150 |
| Start date | Jul 1, 2002 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Apr 22, 2003 |
| Last update posted | May 3, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: